West Virginia · 2026 Regular Session
The purpose of this bill is to add a provision in Schedule I drugs relating to the scheduling of crystalline polymorph psilocybin, if approved by the Food and Drug Administration and the Drug Enforcement Administration, and declare that will be lawful to prescribe, distribute and market this drug.
To House Health and Human Resources (2026-01-22)